An Individualized Online Home-Based Exercise Program for Improving Symptoms in Gynecologic Cancer Survivors

StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Jul 30, 2026 → Jul 30, 2027
See other at-risk trials from Emory University

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Jul 30, 2026 to Jul 30, 2027 Show 4 more changesShow less
    • Study completion pushed from Jul 30, 2027 to Jul 30, 2028
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoints: details revised at 3 of 3 entries
    • Site details revised at 1 of 4 sites
  2. Notable Trial status: Not Yet Recruiting to Recruitingv7 Show 5 more changesShow less
    • Start date changed from estimate of Aug 15, 2025 to Sep 1, 2025
    • Eligibility criteria shortened, about 25 words
    • Secondary endpoints revised (3)
    • Primary endpoints revised (5)
    • Site details revised at 4 of 4 sites
  3. Notable Start date: Jul 1, 2025 to Aug 15, 2025
    • Eligibility criteria shortened, about 11 words
    • Study description shortened, about 6 words
    • Study title shortened, about 1 word
    v6
  4. Notable Start date: Apr 3, 2025 to Jul 1, 2025
    • Site contacts updated at 4 of 4 sites
    v5
  5. Notable Start date: Feb 3, 2025 to Apr 3, 2025v4
Show 2 earlier versionsHide 2 earlier versions
  1. Minor Start date: Jan 5, 2025 to Feb 3, 2025v3
  2. Notable Start date: Dec 1, 2024 to Jan 5, 2025
    • Primary completion date: Jun 30, 2026 to Jul 30, 2026
    • Study completion date: Jun 30, 2027 to Jul 30, 2027
    v2
  1. Minor Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This clinical trial tests an individualized online home-based exercise program in gynecologic cancer survivors and its impact on gut microbiome (the bacteria and microorganisms that live in the digestive system) and symptoms such as pain, fatigue, sleep disturbance, depression, and cognitive impairment. These symptoms can significantly reduce the quality of life (QoL) and survival rate in this cancer population. Thus, promoting physical activity among cancer survivors may help mitigate these severe symptoms. Using online platforms such as Zoom can help participants access an individualized exercise program that meets their specific needs to engage in physical activity and decrease their symptom burden. Home-based exercise, by providing self-chosen time and location and low costs, can address some barriers to physical activity for cancer survivors. An individualized online home-based exercise program may be feasible, and may improve symptoms and quality of life in gynecologic cancer survivors.
Trial Details
NCT Number NCT06709534
Lead Sponsor Emory University
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)
Malignant Female Reproductive System Neoplasm
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov